Mental disorders frequently begin in childhood or adolescence. Psychotropic medications
have various indications for the treatment of mental disorders in this age group and are used …

Objectives Over the past two decades, there has been tremendous growth in research
regarding bipolar disorder (BD) among children and adolescents (ie, pediatric BD [PBD]) …

The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …

Abstract Objectives The 2018 Canadian Network for Mood and Anxiety Treatments
(CANMAT) and International Society for Bipolar Disorders (ISBD) guidelines provided …

Background: Bipolar disorder (BD) is a cyclic mood disorder characterised by alternating
episodes of mania/hypomania and depression interspersed with euthymic periods …

Bipolar disorder (BPD) is a potentially lifelong condition characterised by extreme changes
in mood that may begin in childhood and cause substantial impairment. Over the past …

Background Guidelines for maintenance treatment of juvenile bipolar disorder rely heavily
on evidence from adult studies and relatively brief trials in juveniles, leaving uncertainties …

Aim To appraise the current evidence on the efficacy and safety of lamotrigine (LAM) in the
treatment of pediatric mood disorders (PMD)(ie, Major Depressive disorder [MDD], bipolar …

Bipolar disorder is a chronic and debilitating illness that often begins early in life, with the
first episode frequently occurring in adolescence. 1, 2 Compared with adults, youth …

Childhood onset bipolar disorder (CO-BD) presents a panoply of difficulties associated with
early recognition and treatment. CO-BD is associated with a variety of precursors and …